<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2024-69-6-107-112</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-2098</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FOR THE PRACTITIONER</subject></subj-group></article-categories><title-group><article-title>Мочекаменная болезнь у детей раннего возраста: тактика лечения на примере  клинического наблюдения</article-title><trans-title-group xml:lang="en"><trans-title>Urolithiasis in early childhood: treatment approach illustrated by a case report</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0036-0546</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щапов</surname><given-names>Н. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Shchapov</surname><given-names>N. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щапов Николай Федорович — к.м.н., вед. детский хирург, детский уролог-андролог службы детской торакоабдоминальной хирургии и экстренной хирургической помощи</p><p>143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2 кор. 2</p></bio><bio xml:lang="en"><p>Moscow Region</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6268-7782</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кешишян</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Keshishian</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кешишян Елена Соломоновна — д.м.н., проф., рук. отдела неонатологии и патологии детей раннего возраста легких</p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5523-7046</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Телятников</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Telyatnikov</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Телятников Никита Александрович — врач-педиатр, нефролог отделения детской общеврачебной практики и отделения экстренной помощи</p><p>143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2 кор. 2</p></bio><bio xml:lang="en"><p>Moscow Region</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3552-1335</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буллих</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bullikh</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буллих Павел Владимирович — врач ультразвуковой диагностики отделения лучевой диагностики</p><p>143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2 кор. 2</p></bio><bio xml:lang="en"><p>Moscow Region</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-5908-7096</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Епишов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Epishov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Епишов Валерий Александрович — к.м.н., врач-уролог отделения урологии</p><p>143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2 кор. 2</p></bio><bio xml:lang="en"><p>Moscow Region</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4108-3821</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дегтярев</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Degtyarev</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дегтярев Андрей Сергеевич — ст. врач-педиатр службы стационарной педиатрии, отделения детской общеврачебной практики и отделения экстренной помощи</p><p>143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2 кор. 2</p></bio><bio xml:lang="en"><p>Moscow Region</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2465-807X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куликов Денис Валентинович — врач–детский хирург, рук. службы детской торакоабдоминальной хирургии и экстренной хирургической помощи</p><p>143421 Московская область, г.о. Красногорск, д. Глухово, ул. Рублевское предместье, д. 2 кор. 2</p></bio><bio xml:lang="en"><p>Moscow Region</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>АО «Ильинская больница»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ilyinskaya Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ОСП «Научно-исследовательский клинический институт педиатрии и детской хирургии им. академика Ю.Е. Вельтищева» (Институт Вельтищева) ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>03</day><month>01</month><year>2025</year></pub-date><volume>69</volume><issue>6</issue><fpage>107</fpage><lpage>111</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/2098">https://www.ped-perinatology.ru/jour/article/view/2098</self-uri><abstract><p>Мочекаменная болезнь у детей раннего возраста — редкое заболевание, которое требует особого внимания из-за своей потенциальной сложности и необходимости индивидуального подхода к лечению. В статье представлен анализ случая лечения ребенка в возрасте 5 лет с осложнением мочекаменной болезни. Появлению уролита у ребенка предшествовало лечение острого лимфобластного лейкоза.</p><sec><title>Клиническое наблюдение</title><p>Клиническое наблюдение. В Ильинской больнице находился на лечении мальчик 5 лет с обструкцией правого мочеточника. При обследовании в связи с болевым абдоминальным синдром по данным ультразвукового исследования почек выявлено расширение собирательной системы почки (чашечки до 12 мм, лоханка до 16 мм) и мочеточника (в проксимальном отделе до 6 мм) справа. По данным компьютерной томографии выявлен единичный конкремент, обтурирующий просвет правого мочеточника. Ребенок экстренно оперирован, выполнена цистоуретероскопия, литоэкстракция из правого мочеточника с установкой внутреннего стента. Послеоперационный период протекал с инфекционными осложнениями, которые были эффективно скорректированы. Внутренний стент удален на 6-е послеоперационные сутки. В дальнейшем ребенок находился под наблюдением гематолога и нефролога, данных, подтверждающих рецидив мочекаменной болезни, нет.</p></sec><sec><title>Заключение</title><p>Заключение. Исследование подчеркивает важность комплексного подхода к управлению мочекаменной болезнью у детей, включая внимательный мониторинг и адекватное лечение, особенно в контексте существующих фоновых заболеваний, которые могут усугубить или спровоцировать заболевание. Особое внимание уделяется необходимости адекватного послеоперационного ухода ипрофилактики рецидивов, что обеспечивает благоприятный исход иминимизирует риск повторного формирования камней.</p></sec></abstract><trans-abstract xml:lang="en"><p>Urolithiasis in young children is a rare condition requiring particular attention due to its potential complexity and the necessity of an individualized treatment approach. This article presents a case study of a 5-year-old child treated for urolithiasis following acute lymphoblastic leukemia therapy.</p><sec><title> Case report</title><p> Case report. A 5-year-old boy presented at Ilyinskaya Hospital with right ureteral obstruction. Ultrasound performed due to abdominal pain revealed dilation of the kidney’s collecting system (calyces up to 12 mm, renal pelvis up to 16 mm) and the proximal ureter (up to 6 mm) on the right side. A solitary calculus obstructing the right ureter was identified via computed tomography. The child underwent emergency surgery, including cystoureteroscopy, lithoextraction from the right ureter, and placement of an internal stent. The postoperative period was marked by infectious complications, which were effectively managed. The internal stent was removed on the 6th postoperative day. The patient remained under hematology and nephrology follow-up, with no recurrence of urolithiasis reported.</p></sec><sec><title>Conclusion</title><p>Conclusion: This study emphasizes the necessity of a comprehensive approach in managing pediatric urolithiasis, including careful monitoring and appropriate treatment, particularly in the presence of underlying conditions that may exacerbate or contribute to the disease. Special attention is given to adequate postoperative care and prevention of recurrence, which are essential for a favorable outcome and minimizing the risk of stone reformation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>мочекаменная болезнь у детей</kwd><kwd>урообструкция</kwd><kwd>литоэкстракция</kwd><kwd>профилактика уролитиаза у детей</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>pediatric urolithiasis</kwd><kwd>ureteral obstruction</kwd><kwd>lithoextraction</kwd><kwd>children’s urolithiasis prevention</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Винниченко Л.В., Исмаилова И.А., Делягин В.М. Педиатрические аспекты мочекаменной болезни. Практическая медицина 2018; 16(8): 27–33.</mixed-citation><mixed-citation xml:lang="en">Vinnichenko L.V., Ismailova I.A., Delyagin V.M. Pediatric aspects of urolitiasis. Practical Medicine 2018; 16(8): 27–33. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Barreto L., Jung J.H., Abdelrahim A., Ahmed M., Dawkins G.P.C., Kazmierski M. Medical and surgical interventions for the treatment of urinary stones in children. Cochrane Database Syst Rev 2019; 10(10): CD010784. Published 2019 Oct 9 DOI: 10.1002/14651858.CD010784.pub3</mixed-citation><mixed-citation xml:lang="en">Barreto L., Jung J.H., Abdelrahim A., Ahmed M., Dawkins G.P.C., Kazmierski M. Medical and surgical interventions for the treatment of urinary stones in children. Cochrane Database Syst Rev 2019; 10(10): CD010784. Published 2019 Oct 9 DOI: 10.1002/14651858.CD010784.pub3</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bertrand Y., Mechinaud F., Brethon B., Mialou V., Auvrignon A., Nelken B. et al; SFCE. SFCE (Société Française de Lutte contre les Cancers et Leucémies de l’Enfant et de l’Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey. J Pediatr Hematol Oncol 2008; 30(4): 267–271. DOI: 10.1097/MPH.0b013e318162bd41</mixed-citation><mixed-citation xml:lang="en">Bertrand Y., Mechinaud F., Brethon B., Mialou V., Auvrignon A., Nelken B. et al; SFCE. SFCE (Société Française de Lutte contre les Cancers et Leucémies de l’Enfant et de l’Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey. J Pediatr Hematol Oncol 2008; 30(4): 267–271. DOI: 10.1097/MPH.0b013e318162bd41</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pui C.H., Mahmoud H.H., Wiley J.M., Woods G.M., Leverger G., Camitta B. et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol 2001; 19(3): 697–704. DOI: 10.1200/JCO.2001.19.3.697</mixed-citation><mixed-citation xml:lang="en">Pui C.H., Mahmoud H.H., Wiley J.M., Woods G.M., Leverger G., Camitta B. et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol 2001; 19(3): 697–704. DOI: 10.1200/JCO.2001.19.3.697</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Coiffier B., Altman A., Pui C.H., Younes A., Cairo M.S. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review [published correction appears in J Clin Oncol 2010;28(4):708]. J Clin Oncol 2008; 26(16): 2767–2778. DOI: 10.1200/JCO.2007.15.0177</mixed-citation><mixed-citation xml:lang="en">Coiffier B., Altman A., Pui C.H., Younes A., Cairo M.S. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review [published correction appears in J Clin Oncol 2010;28(4):708. J Clin Oncol 2008; 26(16): 2767–2778. DOI: 10.1200/JCO.2007.15.0177</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Böhles H., Gebhardt B., Beeg T., Sewell A.C., Solem E., Posselt G. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis. J Pediatr 2002; 140(1): 103–109. DOI: 10.1067/mpd.2002.120694</mixed-citation><mixed-citation xml:lang="en">Böhles H., Gebhardt B., Beeg T., Sewell A.C., Solem E., Posselt G. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis. J Pediatr 2002; 140(1): 103–109. DOI: 10.1067/mpd.2002.120694</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Аполихин О.И., Сивков А.В., Просянников М.Ю., Голованов С.А., Войтко Д.А., Анохин Н.В. и др. Кристаллообразующая активность мочи и методы ее измерения. Экспериментальная и клиническая урология 2023; 16(3): 146–153.</mixed-citation><mixed-citation xml:lang="en">Apolikhin O.I., Sivkov A.V., Prosyannikov M.Yu., Golovanov S.A., Voytko D.A., Anokhin N.V. et al. Crystal-forming activity of urine and methods of its measurement. Eksperimental’naya i klinicheskaya urologiya 2023; 16(3): 146–153. (in Russ.) DOI: 10.29188/2222–8543–2023–16–3–146–153</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman S.C., Holcenberg J.S., Finklestein J.Z., Hutchinson R., Kreissman S., Johnson F.L. et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001; 97(10): 2998–3003. DOI: 10.1182/blood.v97.10.2998</mixed-citation><mixed-citation xml:lang="en">Goldman S.C., Holcenberg J.S., Finklestein J.Z., Hutchinson R., Kreissman S., Johnson F.L. et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001; 97(10): 2998–3003. DOI: 10.1182/blood.v97.10.2998</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Coiffier B., Mounier N., Bologna S., Fermé C., Tilly H., Sonet A. et al; Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol 2003; 21(23): 4402–4406. DOI: 10.1200/JCO.2003.04.115</mixed-citation><mixed-citation xml:lang="en">Coiffier B., Mounier N., Bologna S., Fermé C., Tilly H., Sonet A. et al; Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol 2003; 21(23): 4402–4406. DOI: 10.1200/JCO.2003.04.115</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jeha S., Kantarjian H., Irwin D., Shen V., Shenoy S., Blaney S. et al. Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia 2005; 19(1): 34–38. DOI: 10.1038/sj.leu.2403566</mixed-citation><mixed-citation xml:lang="en">Jeha S., Kantarjian H., Irwin D., Shen V., Shenoy S., Blaney S. et al. Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia 2005; 19(1): 34–38. DOI: 10.1038/sj.leu.2403566</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bosly A., Sonet A., Pinkerton C.R., McCowage G., Bron D., Sanz M.A., Van den Berg H. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer 2003; 98(5): 1048–1054. DOI: 10.1002/cncr.11612</mixed-citation><mixed-citation xml:lang="en">Bosly A., Sonet A., Pinkerton C.R., McCowage G., Bron D., Sanz M.A., Van den Berg H. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer 2003; 98(5): 1048–1054. DOI: 10.1002/cncr.11612</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
